ŠKODA, Jan, Karolína BOŘÁNKOVÁ, Patric J. JANSSON, Michael L.-H. HUANG, Renata VESELSKÁ and Desi Raymond RICHARDSON. Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies. Pharmacological Research. London: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2019, vol. 139, JAN, p. 298-313. ISSN 1043-6618. Available from: https://dx.doi.org/10.1016/j.phrs.2018.11.020.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies
Authors ŠKODA, Jan (203 Czech Republic, guarantor, belonging to the institution), Karolína BOŘÁNKOVÁ (203 Czech Republic, belonging to the institution), Patric J. JANSSON, Michael L.-H. HUANG, Renata VESELSKÁ (203 Czech Republic, belonging to the institution) and Desi Raymond RICHARDSON (36 Australia, belonging to the institution).
Edition Pharmacological Research, London, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2019, 1043-6618.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW Full Text
Impact factor Impact factor: 5.893
RIV identification code RIV/00216224:14310/19:00108451
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.phrs.2018.11.020
UT WoS 000458709000028
Keywords in English Cancer stem cells; mitochondria; anti-cancer therapeutics; mitophagy; breast cancer; glioblastoma
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 16/3/2020 14:14.
Abstract
Mitochondria play vital roles in various cellular processes, ranging from cellular metabolism to signal transduction and cell death regulation. As these properties are critical for cancer growth, the mitochondrion has recently become an attractive target for anti-cancer therapies. In addition, it has come to light that mitochondria are crucially involved in the regulation of stem cell identity, differentiation and fate. A similar role for mitochondria has been also demonstrated in malignant stem-like cells termed cancer stem cells (CSCs), which are implicated in progression and resistance of many tumors. In this review, we summarize different mitochondrial functions reported to promote acquisition and maintenance of CSC phenotype and discuss the rationale for their therapeutic targeting. Particular emphasis is given to therapeutics that act directly through modulation of these mitochondrial functions and have recently emerged as promising anti-CSC drugs in pre-clinical studies. This review highlights the intriguing aspects of mitochondrial biology that may have a crucial role in cancer initiation, progression, and resistance and which might facilitate pharmacological targeting. Indeed, understanding of mitochondrial function in the regulation of CSCs will promote the development of novel CSC-targeted therapeutic strategies, which could significantly improve the long-term survival of cancer patients.
Links
NV17-33104A, research and development projectName: Terapeutický potenciál nových thiosemicarbazonů v dětské onkologii: možnosti překonání Pgp-zprostředkované lékové rezistence
PrintDisplayed: 30/8/2024 12:16